19-29529833-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_001146339.2(VSTM2B):​c.312G>C​(p.Gln104His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000194 in 1,549,802 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000021 ( 0 hom. )

Consequence

VSTM2B
NM_001146339.2 missense

Scores

1
10
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.954

Publications

0 publications found
Variant links:
Genes affected
VSTM2B (HGNC:33595): (V-set and transmembrane domain containing 2B) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VSTM2BNM_001146339.2 linkc.312G>C p.Gln104His missense_variant Exon 4 of 5 ENST00000335523.8 NP_001139811.1 A6NLU5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VSTM2BENST00000335523.8 linkc.312G>C p.Gln104His missense_variant Exon 4 of 5 5 NM_001146339.2 ENSP00000335038.6 A6NLU5

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152234
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000652
AC:
1
AN:
153360
AF XY:
0.0000122
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000171
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000208
AC:
29
AN:
1397568
Hom.:
0
Cov.:
32
AF XY:
0.0000189
AC XY:
13
AN XY:
689282
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31550
American (AMR)
AF:
0.00
AC:
0
AN:
35598
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25152
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79006
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48272
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5694
European-Non Finnish (NFE)
AF:
0.0000241
AC:
26
AN:
1078616
Other (OTH)
AF:
0.0000517
AC:
3
AN:
57982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152234
Hom.:
0
Cov.:
34
AF XY:
0.0000134
AC XY:
1
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41476
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68038
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 06, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.312G>C (p.Q104H) alteration is located in exon 4 (coding exon 4) of the VSTM2B gene. This alteration results from a G to C substitution at nucleotide position 312, causing the glutamine (Q) at amino acid position 104 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.71
BayesDel_addAF
Benign
-0.062
T
BayesDel_noAF
Benign
-0.31
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.096
T
Eigen
Uncertain
0.37
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Benign
0.72
D
LIST_S2
Uncertain
0.92
D
M_CAP
Benign
0.055
D
MetaRNN
Uncertain
0.50
D
MetaSVM
Benign
-0.50
T
MutationAssessor
Uncertain
2.6
M
PhyloP100
0.95
PrimateAI
Uncertain
0.79
T
PROVEAN
Uncertain
-3.7
D
REVEL
Benign
0.25
Sift
Uncertain
0.0060
D
Sift4G
Uncertain
0.016
D
Polyphen
0.99
D
Vest4
0.50
MutPred
0.48
Gain of methylation at R102 (P = 0.0588);
MVP
0.24
ClinPred
0.95
D
GERP RS
3.1
Varity_R
0.47
gMVP
0.57
Mutation Taster
=39/61
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1409220575; hg19: chr19-30020740; API